Focal Radiation in the Murine 4T1-luc2 Mammary Cancer Model

The use of immuno-oncology therapies have seen remarkable progress in the last five years and are currently undergoing clinical trial use in combination with a variety of agents including radiation therapy (RT).1 RT is a main-stay in clinical oncology treatments with approximately 60 percent of cancer patients receiving RT at some point during their care. … Continue reading Focal Radiation in the Murine 4T1-luc2 Mammary Cancer Model